论文部分内容阅读
通过单纯化疗及参芪注射液配合化疗治疗胃癌７８例的临床观察，进行增效与减毒的疗效对比，结果证实，参芪注射液可以减低化疗药物的毒副作用，如增加体重（Ｐ＜００５）；保护机体的造血功能，防止化疗中白细胞下降（Ｐ＜００５）；提高机体的细胞免疫功能（Ｐ＜０００１）；增加化疗造型小鼠骨髓细胞总数、单核细胞总数及胸腺重量（Ｐ值分别＜０００１或００５）。参芪注射液的增效作用则表现在提高造型小鼠的抑瘤率和降低化疗药物对小鼠的致死率上
Through simple chemotherapy and Shenqi injection combined with chemotherapy in the treatment of gastric cancer in 78 cases of clinical efficacy, compared with efficacy and attenuation, the results confirmed that Shenqi injection can reduce the toxicity of chemotherapy drugs, such as weight gain (P<0 05);Protect the body’s hematopoietic function, prevent leukopenia in chemotherapy (P<005); Improve the body’s cellular immune function (P<0001); Increase the total number of bone marrow cells and mononuclear cells in mice modeled by chemotherapy Thymus weights (P values <0001 or 005, respectively). The synergistic effect of Shenqi injection shows improvement in the inhibition rate of sculpting mice and decrease of lethality of chemotherapy drugs on mice.